Penetration of ciprofloxacin into female pelvic tissues.
D000890:Anti-Infective Agents / Q000032:analysis / Q000097:blood / Q000378:metabolism*; D002584:Cervix Uteri / Q000032:analysis; D002851:Chromatography, High Pressure Liquid; D002939:Ciprofloxacin; D004717:Endometrium / Q000032:analysis; D005187:Fallopian Tubes / Q000032:analysis*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009215:Myometrium / Q000032:analysis; D010053:Ovary / Q000032:analysis*; D011804:Quinolines / Q000032:analysis / Q000097:blood / Q000378:metabolism*; D014018:Tissue Distribution; D014599:Uterus / Q000032:analysis*
D000890:Anti-Infective Agents; D011804:Quinolines; D002939:Ciprofloxacin